Forbes J A, White R W, White E H, Hughes M K
J Clin Pharmacol. 1980 Jul;20(7):465-74. doi: 10.1002/j.1552-4604.1980.tb01720.x.
The analgesic efficacy of 75, 150, and 300 mg proquazone, a new nonsteroidal antiinflammatory agents, was compared to that of 650 mg aspirin and a placebo in outpatients who had moderate or severe pain following the surgical removal of impacted third molars. Estimates of the relative potency of proquazone to aspirin ranged from 4.9 to 6.2 for total analgesic effect and from 7.7 to 8.4 for peak analgesic effect. Each dosage level of proquazone and aspirin provided significant analgesia compared to placebo and was well tolerated. Adverse effects were transitory and did not appear to be dose related for proquazone.
将75毫克、150毫克和300毫克的丙氧苯宗(一种新型非甾体抗炎药)的镇痛效果,与650毫克阿司匹林和安慰剂在拔除阻生第三磨牙后有中度或重度疼痛的门诊患者中的镇痛效果进行了比较。丙氧苯宗相对于阿司匹林的相对效价估计值,总镇痛效果为4.9至6.2,峰值镇痛效果为7.7至8.4。与安慰剂相比,丙氧苯宗和阿司匹林的每个剂量水平都提供了显著的镇痛效果,且耐受性良好。丙氧苯宗的不良反应是暂时的,似乎与剂量无关。